Actavia Life Sciences, Inc.
RASP · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $75 | $39 | $11 | $14 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $21 | $46 | $34 | $1 |
| Inventory | -$21 | -$46 | -$34 | -$1 |
| Other Curr. Assets | $21 | $46 | $34 | $18 |
| Total Curr. Assets | $96 | $85 | $45 | $33 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $96 | $85 | $45 | $33 |
| Liabilities | – | – | – | – |
| Payables | $960 | $822 | $900 | $952 |
| Short-Term Debt | $211 | $128 | $683 | $522 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1,177 | $0 |
| Other Curr. Liab. | $881 | $732 | $38 | $1,234 |
| Total Curr. Liab. | $2,052 | $1,682 | $2,798 | $2,708 |
| LT Debt | $0 | $92 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $92 | $0 | $1,474 |
| Other Liabilities | $0 | $0 | -$1,492 | -$1,474 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,052 | $1,774 | $2,707 | $2,708 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $772 | $180 | $69 | $69 |
| Retained Earnings | -$28,664 | -$24,221 | -$23,444 | -$22,658 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $25,936 | $22,352 | $20,712 | $19,915 |
| Total Equity | -$1,956 | -$1,689 | -$2,663 | -$2,675 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $96 | $85 | $45 | $33 |
| Net Debt | $136 | $180 | $672 | $508 |